WallStSmart

Amphenol Corporation (APH)vsCTS Corporation (CTS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Amphenol Corporation generates 5042% more annual revenue ($29.01B vs $564.25M). APH leads profitability with a 17.7% profit margin vs 12.4%. APH appears more attractively valued with a PEG of 1.16. APH earns a higher WallStSmart Score of 77/100 (B+).

APH

Strong Buy

77

out of 100

Grade: B+

Growth: 10.0Profit: 9.0Value: 6.7Quality: 6.0
Piotroski: 4/9Altman Z: 2.36

CTS

Buy

59

out of 100

Grade: C

Growth: 4.7Profit: 6.5Value: 5.7Quality: 9.0
Piotroski: 6/9Altman Z: 4.18
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

APHUndervalued (+52.2%)

Margin of Safety

+52.2%

Fair Value

$325.58

Current Price

$161.40

$164.18 discount

UndervaluedFair: $325.58Overvalued

Intrinsic value data unavailable for CTS.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

APH6 strengths · Avg: 9.3/10
Market CapQuality
$210.68B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
33.3%10/10

Every $100 of equity generates 33 in profit

Revenue GrowthGrowth
55.0%10/10

Revenue surging 55.0% year-over-year

EPS GrowthGrowth
59.3%10/10

Earnings expanding 59.3% YoY

Operating MarginProfitability
29.8%8/10

Strong operational efficiency at 29.8%

Free Cash FlowQuality
$1.20B8/10

Generating 1.2B in free cash flow

CTS3 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.1810/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.209/10

Conservative balance sheet, low leverage

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Areas to Watch

APH3 concerns · Avg: 3.0/10
Price/BookValuation
12.8x4/10

Trading at 12.8x book value

Debt/EquityHealth
1.213/10

Elevated debt levels

P/E RatioValuation
41.9x2/10

Premium valuation, high expectations priced in

CTS1 concerns · Avg: 3.0/10
Market CapQuality
$1.63B3/10

Smaller company, higher risk/reward

Comparative Analysis Report

WallStSmart Research

Bull Case : APH

The strongest argument for APH centers on Market Cap, Return on Equity, Revenue Growth. Profitability is solid with margins at 17.7% and operating margin at 29.8%. Revenue growth of 55.0% demonstrates continued momentum.

Bull Case : CTS

The strongest argument for CTS centers on Altman Z-Score, Debt/Equity, Price/Book. PEG of 1.42 suggests the stock is reasonably priced for its growth.

Bear Case : APH

The primary concerns for APH are Price/Book, Debt/Equity, P/E Ratio. A P/E of 41.9x leaves little room for execution misses.

Bear Case : CTS

The primary concerns for CTS are Market Cap.

Key Dynamics to Monitor

APH profiles as a growth stock while CTS is a value play — different risk/reward profiles.

APH carries more volatility with a beta of 1.25 — expect wider price swings.

APH is growing revenue faster at 55.0% — sustainability is the question.

APH generates stronger free cash flow (1.2B), providing more financial flexibility.

Bottom Line

APH scores higher overall (77/100 vs 59/100), backed by strong 17.7% margins and 55.0% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amphenol Corporation

TECHNOLOGY · ELECTRONIC COMPONENTS · USA

Amphenol Corporation is a major producer of electronic and fiber optic connectors, cable and interconnect systems such as coaxial cables. Amphenol is a portmanteau from the corporation's original name, American Phenolic Corp.

CTS Corporation

TECHNOLOGY · ELECTRONIC COMPONENTS · USA

CTS Corporation manufactures and sells sensors, actuators, and connectivity components in North America, Europe, and Asia. The company is headquartered in Lisle, Illinois.

Want to dig deeper into these stocks?